Overview
Madan Jagasia is a Hematologist practicing medicine in Nashville, Tennessee. He has been practicing medicine for over 27 years.
Dr. Jagasia is highly rated in 20 conditions, according to our data. His clinical expertise encompasses Chronic Graft Versus Host Disease (cGvHD), Graft Versus Host Disease (GvHD), Multiple Myeloma, Acute Myeloid Leukemia (AML), and Bone Marrow Transplant.
He is actively involved in clinical research, co-authoring 173 peer reviewed articles and participating in 13 clinical trials.
Specialties
Licenses
Languages Spoken
Gender
Insurance
Accepted insurance can change. Please verify directly with the provider.
Locations
1301 Medical Center Dr Ste 1710, Nashville, TN 37232
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
13 Clinical Trials
Tennessee Oncology Pharmacy Dispensing
Ian Flinn is a Hematologist practicing medicine in Nashville, Tennessee. Dr. Flinn is highly rated in 43 conditions, according to our data. His clinical expertise encompasses Small Lymphocytic Lymphoma (SLL), Chronic Lymphocytic Leukemia (CLL), Chronic B-Cell Leukemia (CBCL), Bone Marrow Transplant, and Bone Marrow Aspiration.
Vanderbilt-Ingram Cancer Center
Brian Rini is a Hematologist practicing medicine in Nashville, Tennessee. Dr. Rini is highly rated in 18 conditions, according to our data. His clinical expertise encompasses Renal Cell Carcinoma (RCC), Chromophobe Renal Cell Carcinoma, WT1-Related Wilms Tumor Syndromes, Nephrectomy, and Prostatectomy.
Tennessee Oncology Pharmacy Dispensing
Jesus Berdeja is a Hematologist practicing medicine in Nashville, Tennessee. Dr. Berdeja is highly rated in 41 conditions, according to our data. His clinical expertise encompasses Multiple Myeloma, Relapsed Refractory Multiple Myeloma (RRMM), Smoldering Multiple Myeloma, Bone Marrow Transplant, and Bone Marrow Aspiration.
Frequently Asked Questions about Dr. Madan Jagasia
How do I make an appointment with Dr. Madan Jagasia?
You can book an appointment with Dr. Madan Jagasia by calling their office at 615-936-8422. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.
Is Dr. Madan Jagasia a top-rated expert for Chronic Graft Versus Host Disease (cGvHD)?
MediFind is an objective health platform that identifies experts based on real-world data. Dr. Madan Jagasia is classified as an Elite expert for Chronic Graft Versus Host Disease (cGvHD), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
What conditions does Dr. Madan Jagasia specialize in?
While Dr. Madan Jagasia is a Hematology, they have specific expertise in Chronic Graft Versus Host Disease (cGvHD), Graft Versus Host Disease (GvHD), and Multiple Myeloma. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Hematology.
Does Dr. Madan Jagasia participate in research or clinical trials?
Yes. Dr. Madan Jagasia has published 173 articles and abstracts on conditions like Chronic Graft Versus Host Disease (cGvHD). You can view a list of Dr. Madan Jagasia's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Elite
- Chronic Graft Versus Host Disease (cGvHD)
- Graft Versus Host Disease (GvHD)
- Distinguished
- Acute Myeloblastic Leukemia without Maturation
- Acute Myeloid Leukemia (AML)Dr. Jagasia isDistinguished. Learn about Acute Myeloid Leukemia (AML).
- Chronic Myelogenous Leukemia (CML)Dr. Jagasia isDistinguished. Learn about Chronic Myelogenous Leukemia (CML).
- Multiple MyelomaDr. Jagasia isDistinguished. Learn about Multiple Myeloma.
- Myelodysplastic Syndrome (MDS)Dr. Jagasia isDistinguished. Learn about Myelodysplastic Syndrome (MDS).
- Primary AmyloidosisDr. Jagasia isDistinguished. Learn about Primary Amyloidosis.
- Advanced
- Acute Lymphoblastic Leukemia (ALL)Dr. Jagasia isAdvanced. Learn about Acute Lymphoblastic Leukemia (ALL).
- Acute Myeloblastic Leukemia with Maturation
- Aplastic AnemiaDr. Jagasia isAdvanced. Learn about Aplastic Anemia.
- Bone Marrow TransplantDr. Jagasia isAdvanced. Learn about Bone Marrow Transplant.
- Childhood Acute Myeloid LeukemiaDr. Jagasia isAdvanced. Learn about Childhood Acute Myeloid Leukemia.
- Diffuse Large B-Cell Lymphoma (DLBCL)
- Experienced
- Acinic Cell Carcinoma of Salivary GlandsDr. Jagasia isExperienced. Learn about Acinic Cell Carcinoma of Salivary Glands.
- Acute Myelomonocytic LeukemiaDr. Jagasia isExperienced. Learn about Acute Myelomonocytic Leukemia.
- Adenoid Cystic CarcinomaDr. Jagasia isExperienced. Learn about Adenoid Cystic Carcinoma.
- Adult Soft Tissue SarcomaDr. Jagasia isExperienced. Learn about Adult Soft Tissue Sarcoma.
- AgranulocytosisDr. Jagasia isExperienced. Learn about Agranulocytosis.
- ALK-Positive Non-Small Cell Lung CancerDr. Jagasia isExperienced. Learn about ALK-Positive Non-Small Cell Lung Cancer.